Page 2 - Onychomycosis Treatment Market Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onychomycosis treatment market report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onychomycosis Treatment Market Report Today - Breaking & Trending Today

Clinical Clarity Grows About Toenail Disorder, Experts Report

The hallmark of retronychia, a disorder of the toes, is layering of new nail growth under prior nail growth. The etiologies vary, affecting treatment choice and likelihood of long-term response. ....

New York , United States , City Of , United Kingdom , University Hospitals In Bristol , American Academy Of Dermatology , Oregon Health Science University , Phoebe Rich , Nail Disorders Clinic , Oregon Health , Science University , University Hospitals , Medscape Medical News , Snail Disease , Tinea Unguium ,

How to protect your nails from getting a fungal infection

How to protect your nails from getting a fungal infection
Updated Mar 08, 2021 | 21:25 IST
Onychomycosis, also called tinea unguium, is the infection that develops in the fingernails and toenails. While the fungal can be triggered by various causes, prevention is always better than cure!
How to protect your nails from getting a fungal infection
No matter how much cleaning and preening we may do in our day-to-day lives, sometimes fungal infection sweeps in its way somehow. If you are someone who likes to paint their nails a lot or is involved in physical work which involves getting your hands dirty, you might be inviting infections. ....

Nail Infection , Nail Fungal Infection , Nail Infection Cure , Nail Infection Prevention , Tinea Unguium , ஆணி தொற்று , ஆணி பூஞ்சை தொற்று , ஆணி தொற்று குணப்படுத்த , ஆணி தொற்று ப்ரெவெந்ஶந் ,

Lupin receives USFDA approval for Tavaborole Topical Solution

The product will be manufactured at Lupin s facility in Pithampur, India.
Tavaborole Topical Solution, 5%, is an oxaborole antifungal indicated for the topical treatment of
onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
Tavaborole Topical Solution (RLD: Kerydin) had estimated annual sales of USD 76 million in the U. S.
(IQVIA MAT December 2020).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid- ....

United States , Anacor Pharmaceuticals Inc , Drug Administration , Tavaborole Topical Solution , United States Food , Kerydin Topical Solution , Anacor Pharmaceuticals , Topical Solution , Capital Market , Health Sciences , Organoboron Compounds , Health Care , Dosage Forms , Routes Of Administration , Food And Drug Administration , Topical Medication , United States Food And Drug Administration , Lupin S , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது மாநிலங்களில் உணவு , மேற்பூச்சு தீர்வு , மூலதனம் சந்தை , ஆரோக்கியம் அறிவியல் , ஆரோக்கியம் பராமரிப்பு , அளவு வடிவங்கள் , மேற்பூச்சு மருந்து ,

Lupin gets tentative approval for Efinaconazole Topical Solution

Lupin announced that it has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration, to market a generic equivalent of Jublia Topical Solution, 10%, of Bausch Health Americas, Inc.
Efinaconazole Topical Solution, 10%, is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. Efinaconazole Topical Solution, 10%, (RLD: Jublia) had estimated annual sales of $222.9 million in the U.S. (IQVIA MAT September 2020).
The announcement was made after market hours on Thursday, 24 December 2020. Shares of Lupin rose 1.37% to settle at Rs 976.15 on Thursday.
The stock hit a 52-week high of Rs 1121.85 on 18 September 2020. The stock hit a 52-week low of Rs 505 on 13 March 2020. ....

South Africa , United States , Asia Pacific , Bausch Health Americas Inc , Drug Administration , Efinaconazole Topical Solution , United States Food , Jublia Topical Solution , Bausch Health Americas , Topical Solution , Latin America , Capital Market , Health Sciences , Life Sciences , Topical Medication , Bausch Health , Wide Range , Innovation Led Transnational Pharmaceutical , Biotechnology Products , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் , ஒன்றுபட்டது மாநிலங்களில் உணவு , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் , மேற்பூச்சு தீர்வு , லத்தீன் அமெரிக்கா ,

Lupin receives USFDA tentative approval for Efinaconazole Topical Solution

Lupin has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration, to market a generic equivalent of Jublia Topical Solution, 10%,
of Bausch Health Americas, Inc.
Efinaconazole Topical Solution, 10%, is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Efinaconazole Topical Solution, 10%, (RLD: Jublia) had estimated annual sales of USD 222.9 million in the U.
S.
(IQVIA MAT September 2020).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedba ....

United States , Bausch Health Americas Inc , Drug Administration , Efinaconazole Topical Solution , United States Food , Jublia Topical Solution , Bausch Health Americas , Topical Solution , Capital Market , Health Sciences , Life Sciences , Topical Medication , Bausch Health , United States Food And Drug Administration , ஒன்றுபட்டது மாநிலங்களில் , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் , ஒன்றுபட்டது மாநிலங்களில் உணவு , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் , மேற்பூச்சு தீர்வு , மூலதனம் சந்தை , ஆரோக்கியம் அறிவியல் , வாழ்க்கை அறிவியல் , மேற்பூச்சு மருந்து , பாஷ் ஆரோக்கியம் ,